Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Turley

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanomaDavid J Propper, David Chao, Jeremy P Braybrooke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosisLeonid L Nikitenko, Russell Leek, Stephen Henderson, et al.
Blood|June 19, 2010
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesHelen Sheldon, Emily Heikamp, Helen Turley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenograftsKrishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Carcinogenesis|July 11, 2012
CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCCSwethajit Biswas, Philip J S Charlesworth, Gareth D H Turner, et al.
The American Journal of Pathology|February 20, 2010
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancerAdrian M Jubb, Elizabeth J Soilleux, Helen Turley, et al.
Cell Metabolism|November 27, 2012
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cellsElena Favaro, Karim Bensaad, Mei G Chong, et al.
Molecular Cancer Research : MCR|February 26, 2014
TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLCJackeline Agorreta, Jianting Hu, Dongxia Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanomaDavid J Propper, David Chao, Jeremy P Braybrooke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosisLeonid L Nikitenko, Russell Leek, Stephen Henderson, et al.
Blood|June 19, 2010
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomesHelen Sheldon, Emily Heikamp, Helen Turley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2012
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyAlan McIntyre, Shalini Patiar, Simon Wigfield, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenograftsKrishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Carcinogenesis|July 11, 2012
CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCCSwethajit Biswas, Philip J S Charlesworth, Gareth D H Turner, et al.
The American Journal of Pathology|February 20, 2010
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancerAdrian M Jubb, Elizabeth J Soilleux, Helen Turley, et al.
Cell Metabolism|November 27, 2012
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cellsElena Favaro, Karim Bensaad, Mei G Chong, et al.
Molecular Cancer Research : MCR|February 26, 2014
TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLCJackeline Agorreta, Jianting Hu, Dongxia Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Pageof 7